Hereditary hemochromatosis is one of the most common inherited disorders and complications of cirrhosis are the most common cause of death in these patients. Hepatic fibrogenesis is mediated by the activation of lipocytes, a process which is characterized by a dramatic phenotypic transformation, wherein lipocytes acquire myofibroblastic features and an enhanced capacity to synthesize collagen. Little is known about the mechanism(s) which initiate the process of lipocyte activation. The long- term goals of this research project are to gain a better understanding of the initiating factors in lipocyte activation, with emphasis placed on the potential roles of oxidative stress, products of Kupffer cells, and intracellular signaling. In experimental iron overload, hepatocellular oxidative stress is accompanied by lipocyte activation and fibrosis adjacent to iron-loaded Kupffer cells. We now propose a series of experiments designed to test the key hypotheses linking oxidative stress, activation of Kupffer cells, and initiation of lipocyte activation.
In Specific Aim 1, we will test the hypothesis that chronic iron overload activates the transcription factors, AP-1 and NF-kappaB, in Kupffer cells in vivo, and that these Kupffer cells produce mediators (TGF-beta, TNF- alpha) that can initiate activation of quiescent lipocytes.
In Specific Aim 2, we will determine whether phagocytosis of damaged iron-loaded hepatocytes by Kupffer cells results in release of products (TGF-beta, TNF-alpha) which can initiate lipocyte activation.
In Specific Aim 3, we will test the hypothesis that oxidative stress can directly induce the activity of AP-1 and NF-kappaB in Kupffer cells in vitro, and that oxidative stress increases the production of TGF-beta and TNF-alpha. In order to better understand the process of lipocyte activation, in Specific Aim 4 we will test the hypothesis that protein kinase C (PKC) plays a role in the initiation and perpetuation of lipocyte activation. These proposed experiments will dramatically expand our knowledge of the initiation of lipocyte activation, a key process in hepatic fibrogenesis. Apart from the obvious clinical relevance to chronic iron overload conditions in humans, these investigations have much broader significance in enhancing our understanding of the relationship between oxidative stress, activation of Kupffer cells and lipocyte activation in hepatic fibrogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK041816-05
Application #
2391421
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1992-09-30
Project End
2000-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Saint Louis University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63103
Chua, Anita C G; Delima, Roheeth D; Morgan, Evan H et al. (2010) Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis. J Hepatol 52:425-31
Rodriguez, Alejandra; Luukkaala, Tiina; Fleming, Robert E et al. (2009) Global transcriptional response to Hfe deficiency and dietary iron overload in mouse liver and duodenum. PLoS One 4:e7212
George, Sarah L; Bacon, Bruce R; Brunt, Elizabeth M et al. (2009) Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology 49:729-38
Olynyk, John K; Trinder, Debbie; Ramm, Grant A et al. (2008) Hereditary hemochromatosis in the post-HFE era. Hepatology 48:991-1001
Kobayashi, Yoshimasa; Bridle, Kim R; Ramm, Grant A et al. (2007) Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells. Liver Int 27:1066-75
Drake, S F; Morgan, E H; Herbison, C E et al. (2007) Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest Liver Physiol 292:G323-8
Bridle, Kim R; Li, Lin; O'Neill, Rosemary et al. (2006) Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells. J Lab Clin Med 147:234-41
Leicester, Katherine L; Olynyk, John K; Brunt, Elizabeth M et al. (2006) Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis. Liver Int 26:559-65
Harrison, Stephen A; Brunt, Elizabeth M; Qazi, Rizwan A et al. (2005) Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 3:604-9
Fleming, Robert E; Britton, Robert S; Waheed, Abdul et al. (2005) Pathophysiology of hereditary hemochromatosis. Semin Liver Dis 25:411-9

Showing the most recent 10 out of 61 publications